| Trial Identifier: | 3475-158 |
| Sponsor: | MSD |
| Start Date: | December 2015 |
| Primary Completion Date: | May 2027 |
| Study Completion Date: | May 2027 |
| Condition: | Anal Cancer; Endometriosis; Lung Cancer; Cancer - Other; Gallbladder Cancer; Mental Health & Behavior - Other; Thyroid Cancer; Cervical Cancer; Colorectal Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary-English |
| Country | Location |
|---|---|
| Australia | North Ryde, Australia |
| Brazil | Sao Paulo, Brazil |
| Chile | Santiago, Chile |
| Colombia | Bogota, Colombia |
| Denmark | Glostrup, Denmark |
| France | Paris, France |
| Germany | Haar, Germany |
| Israel | Hod Hasharon, Israel |
| Italy | Rome, Italy |
| Korea, Republic of | Seoul, Korea, Republic of, 4130 |
| Mexico | Mexico City, Mexico |
| Netherlands | Haarlem, Netherlands |
| Norway | Drammen, Norway |
| Peru | Lima, Peru |
| Poland | Warsaw, Poland |
| Portugal | Paco D'arcos, Portugal |
| Russian Federation | Moscow, Russian Federation |
| South Africa | Midrand, South Africa |
| Spain | Madrid, Spain |
| United States, NJ | New Brunswick, NJ, United States, 08903 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company